BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 27919930)

  • 1. miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation.
    Chen T; Zhou Q; Tang H; Bozkanat M; Yuan JX; Raj JU; Zhou G
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27919930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
    Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
    Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAI-1 is a novel component of the miR-17~92 signaling that regulates pulmonary artery smooth muscle cell phenotypes.
    Chen T; Huang JB; Dai J; Zhou Q; Raj JU; Zhou G
    Am J Physiol Lung Cell Mol Physiol; 2018 Aug; 315(2):L149-L161. PubMed ID: 29644896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
    Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
    Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents Hypoxia-Induced pulmonary hypertension.
    Barnes EA; Ito R; Che X; Alvira CM; Cornfield DN
    Am J Physiol Lung Cell Mol Physiol; 2023 Dec; 325(6):L741-L755. PubMed ID: 37847687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of microRNA-17∼92 in smooth muscle cells attenuates experimental pulmonary hypertension via induction of PDZ and LIM domain 5.
    Chen T; Zhou G; Zhou Q; Tang H; Ibe JC; Cheng H; Gou D; Chen J; Yuan JX; Raj JU
    Am J Respir Crit Care Med; 2015 Mar; 191(6):678-92. PubMed ID: 25647182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
    Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
    Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.
    Schultz K; Murthy V; Tatro JB; Beasley D
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L921-7. PubMed ID: 19304911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
    Shi Z; Wu H; Luo J; Sun X
    Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β.
    Deng B; Du J; Hu R; Wang AP; Wu WH; Hu CP; Li YJ; Li XH
    Life Sci; 2016 Feb; 147():117-24. PubMed ID: 26827991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
    Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
    Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia.
    Kim FY; Barnes EA; Ying L; Chen C; Lee L; Alvira CM; Cornfield DN
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L368-77. PubMed ID: 25399435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis.
    Elamaa H; Kaakinen M; Nätynki M; Szabo Z; Ronkainen VP; Äijälä V; Mäki JM; Kerkelä R; Myllyharju J; Eklund L
    Angiogenesis; 2022 May; 25(2):259-274. PubMed ID: 34997404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.
    Kapitsinou PP; Rajendran G; Astleford L; Michael M; Schonfeld MP; Fields T; Shay S; French JL; West J; Haase VH
    Mol Cell Biol; 2016 May; 36(10):1584-94. PubMed ID: 26976644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
    Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
    Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1.
    Pisarcik S; Maylor J; Lu W; Yun X; Undem C; Sylvester JT; Semenza GL; Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2013 Apr; 304(8):L549-61. PubMed ID: 23418090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
    Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.